An Investigation on Colon Drug Delivery System for Satranidazole Tablet

The colon targeted matrix tablet of satranidazole which is composed of polysaccharides which are susceptible to enzymatic degradation i.e. Guar gum, Xanthan gum, Guar : Xanthan gum in combination at 2 ratios (1:1) and (2:1) and Pectin coated with enteric polymer Eudragit L, Eudragit S and Eudragit RS. The SF7 formulation was found to be able, to release up to 92% of drug into colon. PVP K 30 was used as binder to fabricate a tablet having desired release characteristics. MCC was used as diluent in formulation. Coating materials used were Eudragit L, Eudragit S and Eudragit RS. As the requirement of formulation to bypass the release in stomach and small intestine Eudragit L, Eudragit S and Eudragit RS was suitable polymer in combination. Tablets coated with Eudragit L, Eudragit S and Eudragit RS in ratio of 4:16:5 with less quantity of plasticizer PEG 400 showed excellent film properties and were able to release most of the drug into colon. 10% of coating was found to be optimum. Formulation SF7 was considered as optimum batch as it delivered 96 % of drug into colon. The formulation SF7 can be employed as a promising colon specific drug delivery system of satranidazole.

[1]  K. Pathak,et al.  Optimized prodrug approach: A means for achieving enhanced anti-inflammatory potential in experimentally induced colitis , 2009, Journal of drug targeting.

[2]  K. Pathak,et al.  Optimizing delivery of flurbiprofen to the colon using a targeted prodrug approach , 2008, The Journal of pharmacy and pharmacology.

[3]  J. Fell,et al.  In‐vitro evaluation of khaya and albizia gums as compression coatings for drug targeting to the colon , 2005, The Journal of pharmacy and pharmacology.

[4]  D. Friend New oral delivery systems for treatment of inflammatory bowel disease. , 2005, Advanced drug delivery reviews.

[5]  Yoshinori Masuda,et al.  Scintigraphic evaluation of a novel colon-targeted delivery system (CODES) in healthy volunteers. , 2004, Journal of pharmaceutical sciences.

[6]  E. Akala,et al.  Organic Redox-Initiated Polymerization Process for the Fabrication of Hydrogels for Colon-Specific Drug Delivery , 2003, Drug development and industrial pharmacy.

[7]  Libo Yang,et al.  Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation. , 2002, International journal of pharmaceutics.

[8]  V. Sinha,et al.  Polysaccharides in colon-specific drug delivery. , 2001, International journal of pharmaceutics.

[9]  Y. Jeong,et al.  Evaluation of an intestinal pressure-controlled colon delivery capsules prepared by a dipping method. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[10]  Masao Kobayashi,et al.  An in vitro investigation of the suitability of press-coated tablets with hydroxypropylmethylcellulose acetate succinate (HPMCAS) and hydrophobic additives in the outer shell for colon targeting. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[11]  J. Newton,et al.  The properties of amylose-ethylcellulose films cast from organic-based solvents as potential coatings for colonic drug delivery. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[12]  Masao Kobayashi,et al.  Preparation of enteric coated timed-release press-coated tablets and evaluation of their function by in vitro and in vivo tests for colon targeting. , 2000, International journal of pharmaceutics.

[13]  K. Takada,et al.  Evaluation of intestinal pressure-controlled colon delivery capsule containing caffeine as a model drug in human volunteers. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[14]  K. Takada,et al.  Importance of dissolution process on systemic availability of drugs delivered by colon delivery system. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[15]  Willy Verstraete,et al.  Polymers for colon specific drug delivery. , 1996 .

[16]  T. Tozer,et al.  Glucocorticoid-dextran conjugates as potential prodrugs for colon-specific delivery: hydrolysis in rat gastrointestinal tract contents. , 1994, Journal of pharmaceutical sciences.

[17]  A. Gazzaniga,et al.  Oral delayed-release system for colonic specific delivery☆ , 1994 .

[18]  M. Camilleri,et al.  Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea. , 1993, The New England journal of medicine.

[19]  D. Attwood,et al.  An evaluation of pectin as a carrier for drug targeting to the colon , 1993 .

[20]  J. Hardcastle,et al.  Measurement of gastrointestinal pH profiles in normal ambulant human subjects. , 1988, Gut.

[21]  M. Irving,et al.  Spread of steroid-containing foam after intrarectal administration. , 1979, British medical journal.

[22]  Joseph L. Kanig,et al.  The theory and practice of industrial pharmacy , 1970 .

[23]  S. H. Fox The Theory and Practice of Industrial Pharmacy , 1970 .

[24]  COLON-SPECIFIC DRUG RELEASE SYSTEM - European Patent Office - EP 0759303 A1 , 2010 .

[25]  M. K. Chourasia,et al.  Pharmaceutical approaches to colon targeted drug delivery systems. , 2003, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[26]  B. Mruthyunjayaswamy,et al.  Spectrophotometric methods for the determination of satranidazole , 2003 .

[27]  R. Bodmeier,et al.  Pulsatile drug-delivery systems. , 2001, Critical reviews in therapeutic drug carrier systems.

[28]  G. Hsiue,et al.  Synthesis and characterization of pH-sensitive dextran hydrogels as a potential colon-specific drug delivery system. , 1999, Journal of biomaterials science. Polymer edition.

[29]  L. Vervoort,et al.  Colonic drug targeting. , 1998, Journal of drug targeting.

[30]  P. Watts,et al.  Colonic Drug Delivery , 1997 .

[31]  Ranjit Singh,et al.  Colonic targeting of metronidazole using azo aromatic polymers: Development and characterization , 1997 .

[32]  A. Rubinstein Approaches and opportunities in colon-specific drug delivery. , 1995, Critical reviews in therapeutic drug carrier systems.

[33]  M. Camilleri,et al.  Transit through the proximal colon influences stool weight in the irritable bowel syndrome. , 1992, Gastroenterology.